Recipharm

𝗪𝗛𝗜𝗧𝗘 𝗣𝗔𝗣𝗘𝗥 | 𝗔𝗿𝗲 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗵𝗼𝗹𝗱𝗶𝗻𝗴 𝘂𝘀 𝗯𝗮𝗰𝗸 𝗳𝗿𝗼𝗺 𝗺𝗲𝗲𝘁𝗶𝗻𝗴 𝗰𝗼𝗻𝘀𝘂𝗺𝗲𝗿𝘀’ 𝗽𝗿𝗲𝗯𝗶𝗼𝘁𝗶𝗰 𝗻𝗲𝗲𝗱𝘀? As consumers become more aware of the importance of gut health, nutraceutical companies are increasing the presence of prebiotic materials, including oligosaccharides, in their products to promote digestive health. These compounds are complex, which makes analysing these materials challenging and requires newly developed analytical techniques. To find out more about how we overcame these challenges, read our whitepaper: https://lnkd.in/eJGrbkdv #CDMO #guthealth #prebiotic #oligosaccharides

EVENT | We will be attending the Isranalytica 2025 in Tel Aviv, Israel on January 14-15, at the David Intercontinental Hotel. Meet us at our booth 11 to learn how Recipharm can support you on your drug development journey.  We offer comprehensive services in drug substance and drug product development, including analytical services such as method validation and impurity management. Come and speak to our expert Helen Domeshek,PhD at our booth and let's explore how we can collaborate to bring your innovative therapies to market, and support your analytical challenges. Book your meeting here: https://lnkd.in/dnnm8Qki #Isranalytica2025 #DrugDevelopment #AnalyticalServices #PharmaceuticalIndustry

𝗔𝗿𝗲 𝘆𝗼𝘂 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿 𝗮 𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝘁 𝗽𝗮𝗿𝘁𝗻𝗲𝗿 𝘁𝗼 𝘁𝗮𝗸𝗲 𝘆𝗼𝘂 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗳𝗶𝗹𝗹 & 𝗳𝗶𝗻𝗶𝘀𝗵 𝗹𝗶𝗻𝗲? Recipharm has the capabilities and expertise to get you there. Discover more about our aseptic fill & finish services: https://lnkd.in/eKBXjKev #SterileFillFinish #AsepticFillFinishServices #AsepticFillFinish #FillFinishBiologics #ContractSterileManufacturing #FillFinishCMO 

Efficient and accurate analytical solutions are key to accelerating your product development lifecycle. Recipharm’s 200+ dedicated analytical experts are equipped with state-of-the-art facilities to provide a range of analytical services – encompassing every aspect of analytical development, method validation and testing. Download the fact sheet below to learn more: https://lnkd.in/dgzpifTv #CDMO #QualityAssurance 

Looking for a reliable 𝗖𝗗𝗠𝗢 you can trust throughout the whole journey? Recipharm is your partner through every phase of development, we have experts and capabilities to work with you from API route scouting and synthesis to commercial manufacturing. Whether you're navigating early- or late-stage development or need clinical supply, we're here to ensure seamless progress and high-quality results. We offer scalable capacity and state-of-the-art capabilities tailored to protect and maximize your product's potential—no matter the size or complexity of your project. Let’s discuss how we can support your journey to success! https://lnkd.in/dfU6pRjv #CDMO #FillFinish #OSD #DrugDevelopment

🎄✨𝗧𝗵𝗲 𝗵𝗼𝗹𝗶𝗱𝗮𝘆 𝘀𝗽𝗶𝗿𝗶𝘁 𝗶𝘀 𝗶𝗻 𝗳𝘂𝗹𝗹 𝘀𝘄𝗶𝗻𝗴 𝗵𝗲𝗿𝗲 𝗮𝘁 𝗥𝗲𝗰𝗶𝗽𝗵𝗮𝗿𝗺'𝘀 𝗵𝗲𝗮𝗱 𝗼𝗳𝗳𝗶𝗰𝗲!🎅🌟 This year, we came together for a festive Christmas party, followed by a traditional Swedish Julbord. Working in a global world with colleagues spread across different locations and home offices makes activities like these very special, and important!   We had a lot of fun, and It was a fantastic opportunity to come together as a team, celebrate, and connect on a more personal level. While we look forward to a few days to wind down, we are excited to see what 2025 will bring! #merrychristmas

𝗕𝗿𝗶𝗻𝗴 𝘆𝗼𝘂𝗿 𝗱𝗿𝘂𝗴 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝘁𝗼 𝗺𝗮𝗿𝗸𝗲𝘁 𝗳𝗮𝘀𝘁𝗲𝗿 𝘄𝗶𝘁𝗵 𝗥𝗲𝗰𝗶𝗣𝗿𝗲𝗱𝗶𝗰𝘁. Through a cutting-edge approach, we empower you to make informed decisions to optimise your product and timeline. 𝗥𝗲𝗰𝗶𝗣𝗿𝗲𝗱𝗶𝗰𝘁 is a unique platform that combines statistical modelling and simulation which facilitates QbD in product development, tech-transfer and manufacture of drug products in the most efficient and reliable way. With 𝗥𝗲𝗰𝗶𝗣𝗿𝗲𝗱𝗶𝗰𝘁 we offer an unparalleled understanding of materials and processes, enabling faster and more efficient drug development. Interested to know how 𝗥𝗲𝗰𝗶𝗣𝗿𝗲𝗱𝗶𝗰𝘁 can streamline your next project? Learn more here: https://lnkd.in/dHyEyaUi #DrugDevelopment #TechTrasfer #QbD #CDMO

We were honoured to welcome the Mayor of Leganés, Miguel Ángel Recuenco, and his team to Recipharm in Leganés last week. Their visit highlighted our commitment to innovation and our strong ties with the local community. Several people joined the visit, we also welcomed José Eugenio Marín, Councilor for Economy, Local Development, Trade and Employment, and Alberto Oro and Ignacio Cid representing Invest in Madrid (Regional Office for the promotion and attraction of foreign investment in the Community of Madrid). It was a privilege to showcase our facilities and discuss how we contribute to the economy and employment in Leganes. A big thank you to everyone involved in making this visit a success! We look forward to continue building on this partnership with the local authorities and work together toward a brighter future. https://lnkd.in/dfU6pRjv #AyuntamientodeLeganés #CommunityEngagement #LocalPartnerships #CDMO

Innovative mRNA therapeutics are offering hope for treating a wide range of diseases, from various cancers to infectious illnesses. But one key challenge currently stands in the way of realising the potential of mRNA therapeutics: Their inherent instability. In a recent article in IPI Magazine, our Head of Business Development, Vincenza Pironti, Ph.D., MBA, explores how the right approach to lyophilisation can overcome this challenge and transform the future of mRNA therapies. Read the full article and find out more: https://lnkd.in/dRE3EZ4z   #mRNA #Lyophilisation #DrugDevelopment

🌟Season's Greetings from Recipharm 🎄✨🎁